Technical Analysis for CNST - Constellation Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 12.27 0.00% 0.00
CNST closed down 1.37 percent on Wednesday, April 24, 2019, on 18 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Flat
See historical CNST trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish -0.32%
New Uptrend Bullish -0.32%
Expansion Pivot Buy Setup Bullish Swing Setup -0.32%
Lower Bollinger Band Touch Weakness -0.32%
New Downtrend Bearish 3.11%
50 DMA Support Bullish 3.11%
Lower Bollinger Band Touch Weakness 3.11%
20 DMA Resistance Bearish 3.11%
20 DMA Resistance Bearish -1.84%
20 DMA Resistance Bearish -0.41%

Older signals for CNST ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Constellation Pharmaceuticals, Inc. is a United States-based company, which discovers and develops small molecule therapeutics for the treatment of cancer, inflammatory/immunologic disorders and other diseases. The Company has two clinical-stage oncology development programs: the first program is evaluating a compound, CPI-0610, and the other program is evaluating a compound, CPI-1205. CPI-0610 is a small molecule that inhibits the binding of bromodomain and extra terminal (BET) proteins to chromatin. CPI-1205 is a small molecule that inhibits an enzyme, Enhancer of Zeste Homolog 2 (EZH2). It is in a Phase I clinical study of CPI-0610 in patients with progressive lymphoma; a Phase I clinical study of CPI-0610 in patients with acute leukemia, myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasms; a Phase I clinical study of CPI-0610 in patients with previously treated multiple myeloma, and a Phase 1 clinical study of CPI-1205 in patients with lymphoma.
Cancer Diseases Treatment Of Cancer Lymphoma Multiple Myeloma Myelodysplastic Syndrome Acute Leukemia Ezh2 Myeloproliferative Neoplasm
Is CNST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.04
52 Week Low 4.005
Average Volume 106,421
200-Day Moving Average 0.0
50-Day Moving Average 11.3122
20-Day Moving Average 12.6875
10-Day Moving Average 12.247
Average True Range 0.8183
ADX 31.88
+DI 18.9598
-DI 16.4919
Chandelier Exit (Long, 3 ATRs ) 11.5851
Chandelier Exit (Short, 3 ATRs ) 13.2749
Upper Bollinger Band 13.7444
Lower Bollinger Band 11.6306
Percent B (%b) 0.3
BandWidth 16.660493
MACD Line 0.2926
MACD Signal Line 0.4575
MACD Histogram -0.1649
Fundamentals Value
Market Cap 21.77 Million
Num Shares 1.77 Million
EPS -49.87
Price-to-Earnings (P/E) Ratio -0.25
Price-to-Sales 0.00
Price-to-Book 0.23
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.19
Resistance 3 (R3) 13.16 12.84 13.03
Resistance 2 (R2) 12.84 12.60 12.85 12.98
Resistance 1 (R1) 12.55 12.46 12.39 12.58 12.93
Pivot Point 12.23 12.23 12.15 12.24 12.23
Support 1 (S1) 11.94 11.99 11.78 11.97 11.61
Support 2 (S2) 11.62 11.85 11.63 11.56
Support 3 (S3) 11.33 11.62 11.51
Support 4 (S4) 11.36